The phenotype of a patient with COVID-19: the tactics of making a decision on a timely hospitalization


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

The aim: to study the phenotype of a patient with a new confirmed coronavirus infection COVID-19 and to offer an effective way to make decisions about timely hospitalization in real clinical practice. Material and methods. For the study, we selected patients who received treatment both on an outpatient basis and in a hospital on the basis of Samara State Medical University Clinic in October 2020 with a laboratory-confirmed diagnosis of a new coronavirus infection (in the material obtained with a smear from the nose and oropharynx, SARS-CoV-2 ribonucleic acid was verified by polymerase chain reaction). The primary medical documentation was studied, including anamnesis, taking into account the diseases with which the patient is registered at the dispensary, clinical, laboratory and instrumental data, treatment by class of drugs, and the duration of hospitalization (if confirmed). Results. The study revealed several significant clinical and demographic indicators, lifestyle factors, concomitant pathological conditions and diseases that form a phenotypically unfavorable type of patient with a confirmed new coronavirus infection COVID-19, suggesting some delayed complications of the disease, who is recommended to consider hospitalization regardless of the severity of clinical indicators. Conclusion. The currently known clinical criteria, defined by the Temporary Guidelines approved by the Ministry of Healthcare of Russia, allow medical personnel to determine the conditions for the treatment of patients with COVID-19, but do not always really reflect the likelihood of delayed adverse outcomes. Therefore, in the conditions of real clinical practice, there is a need to optimize the routing for patients of this group, which we propose to improve on the basis of our developed method of making decisions on timely hospitalization of patients with confirmed new coronavirus infection COVID-19 (ARGO-VID-19 scale). A new score assessment of the likelihood of long-term adverse outcomes of the disease, based on the analysis of the phenotype of a patient with COVID-19, involves determining the conditions for treatment in this group of patients in order to minimize cases of late hospitalization and reduce the risk of delayed worse outcomes.

Texto integral

Acesso é fechado

Sobre autores

I. Zolotovskaya

Samara State Medical University of the Ministry of Healthcare of Russia

443099, Samara, 89 Chapaevskaya Str

G. Gimatdinova

Samara State Medical University of the Ministry of Healthcare of Russia

Email: gimatdinova19950icloud.com
443099, Samara, 89 Chapaevskaya Str

I. Davydkin

Samara State Medical University of the Ministry of Healthcare of Russia

Email: dagi20060rambler.ru
443099, Samara, 89 Chapaevskaya Str

V. Sabanova

Samara State Medical University of the Ministry of Healthcare of Russia

Email: victoria_sabanova@mail.ru
443099, Samara, 89 Chapaevskaya Str

Bibliografia

  1. Hoseoki K., Chakraborty A., Sur C. Molecular mechanisms and epidemiology of COVID-19 from the perspective of an allergist. J Allergy Clin Immunol. 2020; 146(2): 285-99. doi: 10.1016/j.jaci.2020.05.033.
  2. Xie J., Ding C., Li J. et al. Characteristics of patients with coronavirus disease (COVID-19) confirmed using an IgM-IgG antibody test. J Med Virol. 2020; 92(10): 2004-10. doi: 10.1002/jmv.2593.
  3. Паздникова Н.П., Глазкова Н.Г., Буреш Д.С. COVID-19: влияние нового типа коронавирусной инфекции на национальную экономику. Экономика: вчера, сегодня, завтра. 2020; 1012А): 169-177. @@Pazdnikova N.P., Glazkova N.G., Buresh D.S. COVID-19: The impact of a new type of coronavirus infection on the national economy. Ekonomika: vchera, segodnya, zavtra = Economy: Yesterday, Today, Tomorrow. 2020; 10(2А): 169-177 (In Russ.). doi: https://dx.doi.org/10.34670/AR.2020.21.54.01 5.
  4. Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. Zhonghua Liu Xing Bing Xue Za Zhi. 2020; 41(2): 145-51. doi: 10.3760/cma.j.issn.0254-6450.2020.02.003.
  5. Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020; 323(13): 1239-42. doi: 10.1001/jama.2020.2648.
  6. Зайцев Д.Н., Шаповалов К.Г., Лукьянов С.А. с соавт. Первые результаты федерального регистра лиц, инфицированных COVID-19, в Забайкальском крае. Забайкальский медицинский вестник. 2020; 2: 25-32. @@Zaitsev D.N., Shapovalov K.G., Lukyanov S.A. et al. First results of the Federal Register of Persons Infected with COVID-19 in Zabaykalsky Krai. Zabaykal'skiy meditsinskiy vestnik = Zabaikalsky Medical Bulletin. 2020; 2: 25-32 (In Russ.).
  7. Временные методические рекомендации, утвержденные Минздрава России «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19)». Версия 9 (от 26.10.2020). Доступ: https://static-0.minzdrav.gov.ru/system/ attachments/attaches/000/052/550/original/MP_COVID-19_%28v9%29.pdf?1603788097 (дата обращения - 01.07.2021). @@Temporary guidelines approved by the Ministry of Health of the Russian Federation «Prevention, diagnosis and treatment of new coronavirus infection (COVID-19)». Version 9 (from 26.10.2020). Available at: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/052/550/original/MP_COVID-19_%28v9%29.pdf?1603788097 (date of access - 01.07.2021) (In Russ.).
  8. Lighter J., Phillips M., Hochman S. et al. Obesity in patients younger than 60 years is a risk factor for COVID-19 hospital admission. Clin Infect Dis. 2020; 71(15): 896-97. doi: 10.1093/cid/ciaa415.
  9. Nishiga M., Wang D.W., Han Y. et al. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020; 17(9): 543-58. doi: 10.1038/s41 569-020-0413.
  10. Madjid M., Safavi-Naeini P., Solomon S.D., Vardeny O. Potential effects of coronaviruses on the cardiovascular system: A review. JAMA Cardiol. 2020; 5(7): 831-40. doi: 10.1001/jamacardio.2020.1286.
  11. Tadic M., Cuspidi C., Mancia G. et al. COVID-19, hypertension and cardiovascular diseases: Should we change the therapy? Pharmacol Res. 2020; 158: 104906. doi: 10.1016/j.phrs.2020.104906.
  12. Leung W.K., To K.-F., Chan P.K. et al. Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology. 2003; 125(4): 1011-17. doi: 10.1016/j.gastro.2003.08.001.
  13. Hussain A., Bhowmik B., do Vale Moreira N.C. COVID-19 and diabetes: Knowledge in progress. Diabetes Res Clin Pract. 2020; 162: 108142. doi: 10.1016/j.diabres.2020.108142.
  14. Guan W.J., Liang W.H., Zhao Y. et al. Comorbidity and its impact on 1 590 patients with COVID-19 in China: A nationwide analysis. Eur Respir J. 2020; 55(5): 2000547. doi: 10.1183/13993003.00547-2020.
  15. Sahin A.R., Erdogan A., Agaoglu P.M. et al. 2019 novel coronavirus (COVID-19) outbreak: A review of the current literature. EJMO. 2020; 4(1): 1-7. doi: 10.14744/ejmo.2020.12220.
  16. Fan Z., Chen L., Li J. et al. Clinical features of COVID-19-related liver functional abnormality. Clin Gastroenterol Hepatol. 2020; 18(7): 1 561-66. doi: 10.1016/j.cgh.2020.04.002.
  17. Verity R., Okell L.C., Dorigatti I. et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. 2020; 20(6): 669-77. doi: 10.1016/S1473-3099(20)30243-7.
  18. Huang C., Wang Y., Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223): 497-506. doi: 10.1016/S0140-6736(20)30183-5.
  19. Tang Y.-W., Schmitz J.E., Persing D.H., Stratton C.W. Laboratory diagnosis of COVID-19: Current issues and challenges. J Clin Microbiol. 2020; 58(6): e00512-20. doi: 10.1128/JCM.00512-20.
  20. Cascella M., Rajnik M., Cuomo A. et al. Features, evaluation and treatment coronavirus (COVID-19). StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2020 Jan. PMID: 321 50360. Bookshelf ID: NBK554776.
  21. Yang Y., Lu Q., Liu M. et al. Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China. medRxiv. 2020. doi: 10.1101/2020.02.10.20021675.
  22. Морозов С.П., Гомболевский В.А., Чернина В.Ю. с соавт. Прогнозирование летальных исходов при COVID-19 по данным компьютерной томографии органов грудной клетки. Туберкулез и болезни легких. 2020; 6: 7-14. [Morozov S.P., Gombolevsky V.A., Chernina V.Yu. et al. Predicting deaths in COVID-19 based on chest computed tomography. Tuberkulez i bolezni legkikh = Tuberculosis and Lung Disease. 2020; 6: 7-14 (In Russ.)]. doi: https://dx.doi.org/10.21292/2075-1230-2020-98-6-7-14.
  23. Lon C., Xu H., Shen Q. et al. Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT? Eur J Radiol. 2020; 126: 108961. doi: 10.1016/j.ejrad.2020.108961.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2021